Anthranol
Title: Anthranol
CAS Registry Number: 529-86-2
CAS Name: 9-Anthracenol
Additional Names: 9-anthrol; 9-hydroxyanthracene
Molecular Formula: C14H10O
Molecular Weight: 194.23
Percent Composition: C 86.57%, H 5.19%, O 8.24%
Literature References: Prepd by dissolving anthrone in 5 to 10% boiling NaOH soln, cooling to -5° and pouring in cooled 5% H2SO4: Meyer, Ann. 379, 56 (1911). Also prepared from anthraquinone.
Properties: Needles from glacial acetic acid, plates from dil alcohol. Orthorhombic, mp 120° (if bath is heated to 110°). Sinters at 120°, mp 152° (if bath is cold at start). Absorption spectrum (of acetate): Barnett et al., J. Chem. Soc. 1928, 885. Sol in most solvents with blue fluorescence. The solid is fairly stable when kept dry. In solution it changes quickly to anthrone. Recrystallizations of anthranol may lead to a less pure compound.
Melting point: mp 120° (if bath is heated to 110°); mp 152° (if bath is cold at start)
 
Derivative Type: Acetate
Molecular Formula: C16H12O2
Molecular Weight: 236.27
Percent Composition: C 81.34%, H 5.12%, O 13.54%
Properties: Crystals from petr ether, mp 134°.
Melting point: mp 134°
 
Derivative Type: Benzoate
Molecular Formula: C21H14O2
Molecular Weight: 298.33
Percent Composition: C 84.55%, H 4.73%, O 10.73%
Properties: Crystals from pyridine + alcohol, mp 170-172°.
Melting point: mp 170-172°
 
Derivative Type: Methyl ether
Molecular Formula: C15H12O
Molecular Weight: 208.26
Percent Composition: C 86.51%, H 5.81%, O 7.68%
Properties: Crystals from alcohol, mp 97-98°.
Melting point: mp 97-98°
 
Derivative Type: Ethyl ether
Molecular Formula: C16H14O
Molecular Weight: 222.28
Percent Composition: C 86.45%, H 6.35%, O 7.20%
Properties: Crystals from methanol, mp 73°.
Melting point: mp 73°
 
Use: In the manuf of dyes.

Others monographs:
BromolysergideMinoxidilTamarind2,4,5-T
Sodium Chromate(VI)5-Ethyl-2-picolineCarboxin2-Naphthalenesulfonic Acid
AnthrarufinBis(1,2-dimethylpropyl)boraneBuclosamideChlophedianol
Aluminum CarbideTipepidineUrethan10,10'-Oxydiphenoxarsine
©2016 DrugLead US FDA&EMEA